首页> 外文期刊>Antimicrobial agents and chemotherapy. >Malaria treatment with atovaquone-proguanil in malaria-immune adults: implications for malaria intervention trials and for pre-exposure prophylaxis of malaria.
【24h】

Malaria treatment with atovaquone-proguanil in malaria-immune adults: implications for malaria intervention trials and for pre-exposure prophylaxis of malaria.

机译:在接受疟疾免疫的成年人中使用阿托伐醌-异丙胍治疗疟疾:对疟疾干预试验和暴露前预防疟疾的影响。

获取原文
获取原文并翻译 | 示例
           

摘要

Eighty adults in areas of Kenya where malaria is holoendemic received presumptive treatment with atovaquone-proguanil and were followed closely. The time to the first Plasmodium falciparum parasitemia was 32 days. This prolonged prophylaxis period has implications for study design when used in malaria intervention trials and cautiously suggests clinical investigation of potential preexposure prophylaxis of malaria.
机译:在肯尼亚是疟疾流行区的肯尼亚地区,有80名成年人接受了阿托伐醌-异丙胍的推定治疗,并受到密切跟踪。首次恶性疟原虫寄生虫病的时间为32天。当在疟疾干预试验中使用时,这种延长的预防期对研究设计具有影响,并谨慎地建议对潜在的疟疾预暴露预防进行临床研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号